News Column

Osiris Therapeutics Elevates Frank Czworka to VP and GM of Wound Care

February 17, 2014

Osiris Therapeutics, Inc., a stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets has announced the promotion of Frank D. Czworka, Jr., to Vice President and General Manager of Wound Care.

Additionally, the board voted unanimously for his appointment as a corporate officer of Osiris. Czworka joined Osiris in August 2011 and has been leading all aspects of Grafix commercial and clinical development.

In a release, the Company said that Czworka has over 20 years of sales and marketing experience in the Life Science industry with a demonstrated track record of building specialty sales forces and developing product access in managed markets, including public and private payer accounts. Prior to Osiris, he served as Vice President of Sales at MedImmune, responsible for leading a 450 person sales team for Synagis, a $1B monoclonal antibody for RSV and FluMist, the first intranasal influenza vaccine. He also led sales efforts at other biotech organizations including TAP Pharmaceuticals and Auxilium Pharmaceuticals. Czworka holds a bachelors degree in Marketing from the University of Central Florida.

((Comments on this story may be sent to health@closeupmedia.com))


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Health & Beauty Close - Up


Story Tools